https://www.business-standard.com/article/companies/bharat-biotech-to-begin-trials-of-intranasal-vaccine-for-covid-in-feb-mar-121010800340_1.html
The Phase-1 trials will be conducted in Saint Louis University’s Vaccine and Treatment Evaluation Unit
Bharat Biotech to begin trials of intranasal vaccine for Covid in Feb-Mar
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- Research: To Retain Employees, Promote Them Before the Job Market Heats Up
- Does Returning to the Office Support Your Company’s Strategy?
- “I’m Afraid We Are Automating This Work Without Really Understanding It”
- How to Develop Your Executive Presence
- The Consumer Psychology of Adopting AI
- Forex Today: Market focus shifts to February PMI data
- Japanese Yen sticks to intraday losses; bears lack conviction amid hawkish BoJ expectations
- Australian Dollar holds losses as the US Dollar remained firm ahead of PMI release
- UK Retail Sales jump 1.7% MoM in January vs. 0.3% expected
- United Kingdom Public Sector Net Borrowing below forecasts (£20B) in January: Actual (£-15.442B)
More from UncategorizedMore posts in Uncategorized »
- Led Zeppelin’s Robert Plant Received Nearly $9 Million in Royalty Dividends Last Year, Financial Statements Show
- Research: To Retain Employees, Promote Them Before the Job Market Heats Up
- Does Returning to the Office Support Your Company’s Strategy?
- “I’m Afraid We Are Automating This Work Without Really Understanding It”
- How to Develop Your Executive Presence
- The Consumer Psychology of Adopting AI
- Forex Today: Market focus shifts to February PMI data
- Japanese Yen sticks to intraday losses; bears lack conviction amid hawkish BoJ expectations
- Australian Dollar holds losses as the US Dollar remained firm ahead of PMI release
- UK Retail Sales jump 1.7% MoM in January vs. 0.3% expected
